Clinical Trial Update: High Dose Vitamin C in Cardiac Surgery Patients [Phase 1]

View source ↗

Summary

Phase 1 trial updating high-dose vitamin C in cardiac surgery patients; terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Complications Due to Coronary Artery Bypass Graft
• Disorder of Vitamin
• Heart Valve Disease

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Disorder of Vitamin C, Atrial Fibrillation | Phase 1 | Status: TERMINATED | Results posted: 2019-06-24